Brief: Helix Biopharma signs LOI with Ken Poland
22/02/2017 12:34
Feb 22 (Reuters) - Helix Biopharma Corp HBP.TO :
* Helix Biopharma Corp - signed non-binding loi with ken
poland in support of European centre for cancer immunotherapy
* Helix Biopharma-LOI contemplates proposed investment by
Ken Poland of about $30 million
Source text for Eikon: ID:nCCN1pxl68
Further company coverage: HBP.TO
((bangalore.newsroom@thomsonreuters.com;))
Recent news on Helix Biopharma
See all newsBrief: Helix Biopharma Reports Q3 Loss Per Share C$0.02
Brief: Helix Biopharma Intends To File Interim Consolidated Financial Statements By July 30
Brief: Helix Biopharma To Divest Remaining Ownership Of Polish Subsidiary
Brief: Helix Biopharma Says Expects To File Interim Disclosure Documents By July 30, 2020
Brief: Helix Biopharma Says L-Dos47 Phase I Lung Cancer Trial Data To Be Released At Asco 2020